$0.165
-0.001 (-0.42%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VTGN por análisis de gráficos similares
Alphio's VTGN stock price prediction model matches the current Vistagen Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.16 (-2.98%). The 1-week path is $0.15 (-6.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vistagen Therapeutics Inc?
Vistagen Therapeutics is not a good buy right now due to its current price of $0.1645, which is near its 52-week low of $0.16, and a troubling RSI of 32.407 indicating oversold conditions. The company has experienced a staggering 95.87% decline over the past year, and despite a revenue surge to $1.27 million, it reported a net loss of $13 million in the last quarter, reflecting ongoing financial struggles. The main risk is the failure of its drug trial, which caused a 71% drop in stock price, highlighting significant volatility and uncertainty.
VTGN cerró en $0.16 el Friday, tras bajar -0.42%
Vistagen Therapeutics Inc (VTGN) last closed at $0.1645, losing -0.42%. These facts feed the 1-day and 1-week VTGN price prediction above.
Consenso de analistas
Vistagen Therapeutics Inc (VTGN): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Vistagen Therapeutics Inc (VTGN) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VTGN, ordenadas por similitud.
Análisis de estacionalidad de VTGN
Historically the probability of a positive November return for VTGN is 43.18%. November offers the highest probability of a positive month at 43.18%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.